<DOC>
	<DOCNO>NCT01082263</DOCNO>
	<brief_summary>A Phase I , Drug-Drug Interaction Study Midazolam Lurasidone HCl .</brief_summary>
	<brief_title>Midazolam Drug-Drug Interaction Study With Lurasidone HCl</brief_title>
	<detailed_description>lurasidone 120 mg , midazolam 5 mg To compare single-dose pharmacokinetic profile midazolam 5 mg administer alone vs. administer single-dose lurasidone 120 mg. To compare single dose pharmacokinetic profile midazolam 5 mg administer alone vs. administer steady state dose lurasidone 120 mg .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Lurasidone Hydrochloride</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>1 . Diagnosis schizophrenia , schizoaffective disorder , schizophreniform disorder 2 . Females participate study : unable child OR willing remain abstinent Day 5 90 day discharge ; OR willing use effective method doublebarrier birth control Day 5 90 day discharge . 3 . Males must willing remain sexually abstinent use effective method birth control Day 5 90 day discharge . 4 . Able agree remain prior antipsychotic medication duration study . 1 . Known presence history renal hepatic insufficiency . 2 . A history presence abnormal electrocardiogram ( ECG5 . Known history presence clinically significant intolerance antipsychotic medication . 3 . Significant orthostatic hypotension ( i.e . drop systolic blood pressure 30 mmHg and/or drop diastolic blood pressure 20 mmHg standing ) . 4 . Presence history ( within last year ) medical surgical condition ( e.g . gastrointestinal disease ) might interfere absorption , metabolism , excretion orally administer lurasidone . 5 . Participated another clinical trial receive investigational product within 30 day prior drug administration . 6 . Use concomitant medication prolong QT/QTc interval within 14 day prior Day 5 followup include limited list Appendix 19.5 . 7 . Received depot neuroleptic unless last injection least 1 treatment cycle Day 5 . 8 . Difficulty fast consume FDA high fat meal . 9 . At risk midazolam dose respiratory disease impair gag reflex , opinion investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>DDI study Midazolam Lurasidone HCl</keyword>
	<keyword>Male Female</keyword>
</DOC>